These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1288975)

  • 1. Effects of atrial natriuretic factor on patients with renovascular hypertension.
    Zhang WG; Liu LS; Zheng DY; Liu GZ; Jin L; Zhao XW; Ren B
    Chin Med J (Engl); 1992 Sep; 105(9):732-7. PubMed ID: 1288975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antihypertensive and aldosterone-lowering effects of synthetic atrial natriuretic factor in renin-dependent renovascular hypertension.
    Volpe M; Odell G; Kleinert HD; Camargot MJ; Laragh JH; Lewicki JA; Maack T; Vaughan ED; Atlas SA
    J Hypertens Suppl; 1984 Dec; 2(3):S313-5. PubMed ID: 6242558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of atrial natriuretic factor on blood pressure and the renin-angiotensin-aldosterone system.
    Atlas SA; Volpe M; Sosa RE; Laragh JH; Camargo MJ; Maack T
    Fed Proc; 1986 Jun; 45(7):2115-21. PubMed ID: 2940120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of felodipine on natriuresis, atrial natriuretic factor, the renin-angiotensin-aldosterone system, and blood pressure in essential hypertension.
    Cerasola G; Cottone S; Mangano MT; D'Ignoto G; Pinto A; Carone MB
    Clin Ther; 1988; 10(6):694-703. PubMed ID: 2975530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effects of verapamil and volume overload on atrial natriuretic factors and the renin-angiotensin aldosterone-vasopressin system.
    Buckley JW; Hedner T; Masotto C; Posvar E; Negro-Villar A; Cubeddu LX
    J Clin Pharmacol; 1992 Dec; 32(12):1120-7. PubMed ID: 1487551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Some physiopathological aspects of atrial natriuretic factor.
    Garcia R; Cantin M; Cusson JR; Genest J; Gutkowska J; Larochelle P; Schiffrin EL; Thibault G
    J Hypertens Suppl; 1986 Jun; 4(2):S125-9. PubMed ID: 2941534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Verapamil sustained-release in renal parenchymal hypertension: effect on blood pressure, kidney function, angiotensin II, aldosterone, arginine vasopressin, atrial natriuretic peptide, and lipoproteins.
    Eiskjaer H; Pedersen EB; Rasmussen LM; Jespersen B
    J Cardiovasc Pharmacol; 1989; 13 Suppl 4():S17-22. PubMed ID: 2475677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal tubular sensitivity to atrial natriuretic factor in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    J Hypertens; 1994 Apr; 12(4):439-47. PubMed ID: 8064168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
    Fontana F; Guardigli G; Cappelli M; Bernardi P
    G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atrial natriuretic factor on natriuresis and cGMP in patients with essential hypertension.
    Cusson JR; Hamet P; Gutkowska J; Kuchel O; Genest J; Cantin M; Larochelle P
    J Hypertens; 1987 Aug; 5(4):435-43. PubMed ID: 2822796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular, renal, and endocrine responses to low-dose atrial natriuretic peptide in the fluid-balanced New Zealand genetically hypertensive rats with and without endogenous arginine vasopressin.
    Abu-Amarah I; Balment RJ
    Can J Physiol Pharmacol; 1999 Feb; 77(2):102-10. PubMed ID: 10535700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular, renal and endocrine responses to low doses of atrial natriuretic factor in mild essential hypertension.
    Cusson JR; Thibault G; Kuchel O; Hamet P; Cantin M; Larochelle P
    J Hum Hypertens; 1989 Apr; 3(2):89-96. PubMed ID: 2547952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial natriuretic factor (auriculin): structure and biological effects.
    Atlas SA; Kleinert HD; Camargo MJ; Volpe M; Laragh JH; Lewicki JA; Maack T
    J Clin Hypertens; 1985 Jun; 1(2):187-98. PubMed ID: 2941526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Behavior of the renin-angiotensin-aldosterone system and vasopressin secretion in patients with renovascular hypertension or small kidney].
    Wieçek A; Kokot F
    Z Gesamte Inn Med; 1985 Mar; 40(6):172-6. PubMed ID: 3890386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship of the renin-angiotensin-aldosterone system with auricular natriuretic factor in its response to the action of thiazide diuretics and to nifedipine, a sustained-release calcium antagonist].
    Ocón J; Mora-Macià J; Castellet R; del Río G
    Med Clin (Barc); 1994 Jan; 102(2):41-5. PubMed ID: 8133694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal renal tubular response to changes of sodium intake in hypertensive man.
    Bruun NE; Skøtt P; Damkjaer Nielsen M; Rasmussen S; Schütten HJ; Leth A; Pedersen EB; Giese J
    J Hypertens; 1990 Mar; 8(3):219-27. PubMed ID: 2159502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrial natriuretic factor (ANF) in experimental and human hypertension.
    Cantin M; Garcia R; Thibault G; Kuchel O; Gutkowska J; Larochelle P; Hamet P; Schiffrin EL; Genest J
    Clin Invest Med; 1987 Nov; 10(6):561-7. PubMed ID: 2964319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of human atrial natriuretic factor-(99-126) on plasma and brain vasopressin in stroke-prone spontaneously hypertensive rats].
    Sun SD; Zhang Q; Zhao XW; Tang J
    Sheng Li Xue Bao; 1989 Feb; 41(1):56-62. PubMed ID: 2527409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial natriuretic factor after dopamine infusion in healthy subjects and in congestive heart failure.
    Fontana F; Bernardi P; Ruffini M; Capelli M
    Eur Heart J; 1991 Jul; 12(7):803-6. PubMed ID: 1832381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
    Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.